We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$9.85B
AUM Growth
+$1.07B
Cap. Flow
+$452M
Cap. Flow %
4.59%
Top 10 Hldgs %
25.39%
Holding
161
New
8
Increased
88
Reduced
54
Closed
4

Top Buys

Rank Stock Value
1
AVLR
Avalara, Inc.
AVLR
+$71.1M
2
PCTY icon
Paylocity
PCTY
+$53.6M
3
FVRR icon
Fiverr
FVRR
+$49.1M
4
GKOS icon
Glaukos
GKOS
+$45M
5
VMEO
Vimeo
VMEO
+$44.6M

Sector Composition

Rank Sector Weight
1 Technology 36.36%
2 Healthcare 23.55%
3 Industrials 15.25%
4 Consumer Discretionary 9.1%
5 Communication Services 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOW icon
51
ServiceNow
NOW
$120B
$72.5M 0.74%
659,900
+22,175
+3% +$2.25M
PRO
52
DELISTED
PROS Holdings
PRO
$69.7M 0.71%
1,530,553
+65,213
+4% +$2.88M
HSKA
53
DELISTED
Heska Corp
HSKA
$67.8M 0.69%
294,990
+13,872
+5% +$2.72M
KIDS icon
54
OrthoPediatrics
KIDS
$515M
$67.7M 0.69%
1,071,359
+52,146
+5% +$3M
GOOGL icon
55
Alphabet (Google) Class A
GOOGL
$4.12T
$66.1M 0.67%
541,380
+23,060
+4% +$2.69M
FRPT icon
56
Freshpet
FRPT
$3.04B
$64.4M 0.65%
395,378
-80,664
-17% -$13.8M
CRL icon
57
Charles River Laboratories
CRL
$11.4B
$61.4M 0.62%
166,036
+10,657
+7% +$3.56M
PRLB icon
58
Protolabs
PRLB
$1.71B
$60.2M 0.61%
655,599
+29,992
+5% +$2.95M
HCAT icon
59
Health Catalyst
HCAT
$159M
$59.8M 0.61%
1,076,457
+51,747
+5% +$2.76M
PRAA icon
60
PRA Group
PRAA
$680M
$56.4M 0.57%
1,465,436
+71,914
+5% +$2.76M
ILMN icon
61
Illumina
ILMN
$29.1B
$56.2M 0.57%
121,985
+7,686
+7% +$3.1M
V icon
62
Visa
V
$709B
$54.3M 0.55%
232,377
+9,078
+4% +$2.08M
INOV
63
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$54.1M 0.55%
1,586,803
+73,143
+5% +$2.26M
POWI icon
64
Power Integrations
POWI
$3.16B
$53.8M 0.55%
656,197
+30,573
+5% +$2.47M
AOS icon
65
A.O. Smith
AOS
$8.53B
$53.6M 0.54%
744,245
-342,871
-32% -$23.7M
PHR icon
66
Phreesia
PHR
$684M
$53.6M 0.54%
874,140
+322,910
+59% +$16.8M
MEDP icon
67
Medpace
MEDP
$16.2B
$52.3M 0.53%
296,140
+13,429
+5% +$2.32M
PNTG icon
68
Pennant Group
PNTG
$1.44B
$52.2M 0.53%
1,275,847
+486,390
+62% +$18.9M
EYE icon
69
National Vision
EYE
$1.75B
$51.4M 0.52%
1,005,978
+47,580
+5% +$2.33M
WSC icon
70
WillScot Mobile Mini Holdings
WSC
$4.39B
$51.3M 0.52%
1,841,235
-971,288
-35% -$27.9M
FIVN icon
71
FIVE9
FIVN
$2.11B
$50M 0.51%
272,391
+9,154
+3% +$1.58M
GSHD icon
72
Goosehead Insurance
GSHD
$1.66B
$48.6M 0.49%
381,808
+142,221
+59% +$14.5M
DSGX icon
73
Descartes Systems
DSGX
$6.68B
$47.6M 0.48%
688,771
+17,621
+3% +$1.11M
VMEO
74
DELISTED
Vimeo
VMEO
$47.5M 0.48%
+970,260
New +$44.6M
FND icon
75
Floor & Decor
FND
$6.01B
$46.5M 0.47%
439,992
-293,331
-40% -$30.4M

Similar funds

Riverbridge Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Riverbridge Partners held 161 positions worth $9.85B, up 12% from $8.78B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Riverbridge Partners deployed $452M of net new capital in Q2 2021, opening 8 new positions and adding to 88 existing holdings. Its largest new stake was Glaukos: 547,658 shares worth $46.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AMN Healthcare, an estimated $52M trimmed.

  • Riverbridge Partners's largest Q2 2021 buy was Glaukos: 547,658 shares worth $46.5M.
  • Riverbridge Partners added most to Avalara, Inc. in Q2 2021, an estimated $71.1M increase.
  • Riverbridge Partners's biggest Q2 2021 reduction was AMN Healthcare, cutting an estimated $52M.
  • Riverbridge Partners fully exited Calavo Growers in Q2 2021, selling an estimated $25.2M.
  • Riverbridge Partners's ten largest holdings make up 25% of its $9.85B portfolio in Q2 2021.
  • Riverbridge Partners opened 8 new positions and closed 4 in Q2 2021.
  • Riverbridge Partners's portfolio value rose 12% quarter-over-quarter to $9.85B.

Based on Riverbridge Partners's 13F filing for Q2 2021, filed 26 Jul 2021.